Introduction
Triphala is a classical Ayurvedic formulation composed of Haritaki (Terminalia chebula), Bibhitaki (Terminalia bellirica), and Amalaki (Emblica officinalis). It is widely recognized for its Rasayana and systemic cleansing properties. In the context of rheumatoid arthritis, correlated with Amavata, Triphala is associated with supportive roles in inflammation modulation, oxidative stress reduction, and systemic balance restoration.
Pathophysiological relevance in rheumatoid arthritis
Rheumatoid arthritis is a chronic autoimmune inflammatory disorder characterized by persistent synovial inflammation, joint degeneration, and systemic immune dysregulation. In Ayurvedic correlation, Amavata is linked with Aama accumulation and Vata-Kapha imbalance, leading to pain, stiffness, swelling, and progressive joint impairment. Oxidative stress and inflammatory mediator activity contribute significantly to disease progression, highlighting the relevance of antioxidant-based interventions.
Therapeutic relevance of Triphala in Amavata
Within Ayurvedic frameworks, Triphala is considered a systemic Rasayana with detoxifying and regulatory properties. Its relevance in Amavata is associated with reduction of Aama burden and support of metabolic and digestive equilibrium, which are central to disease pathogenesis.
Key therapeutic roles include:
- Antioxidant support: Contributes to reduction of oxidative stress burden in chronic inflammation
- Anti-inflammatory modulation: Supports regulation of inflammatory responses in joint pathology
- Metabolic balance: Associated with digestive and systemic functional regulation in Aama-related conditions 1
Clinical application in rheumatoid arthritis
Clinical use of Triphala is described as part of supportive Ayurvedic management strategies in chronic inflammatory disorders. Its integration is aligned with systemic detoxification and long-term metabolic correction approaches in Amavata.
Core application aspects include:
- Use as a supportive Rasayana formulation in chronic inflammatory conditions
- Inclusion in Amavata management protocols targeting systemic imbalance
- Application in digestive and metabolic regulation strategies within Ayurvedic practice
Pharmacological and mechanistic basis
Pharmacological evaluations of Triphala demonstrate antioxidant, anti-inflammatory, and immunomodulatory activities. These effects are associated with scavenging of free radicals, regulation of inflammatory mediators, and modulation of immune responses. Such multi-target activity supports its relevance in chronic inflammatory and autoimmune disease frameworks such as rheumatoid arthritis.
Conclusion
Triphala demonstrates significant therapeutic relevance in rheumatoid arthritis through its combined antioxidant, anti-inflammatory, and immunomodulatory properties. Its role in Amavata management reflects its capacity to support systemic detoxification, metabolic balance, and inflammatory regulation in chronic joint disorders. 2
References:
- Sireeratawong S, Jaijoy K, Soonthornchareonnon N. Evaluation of anti-inflammatory and antinociceptive activity of Triphala recipe. Afr J Tradit Complement Altern Med. 2012;10(2):246-250. Published 2012 Dec 31. doi:10.4314/ajtcam.v10i2.8. https://pmc.ncbi.nlm.nih.gov/articles/PMC3746571/
- Intakhiao S, Prakobkaew N, Buddhisa S, et al. Ameliorative Effects of Triphala Supplementation on Oxidative Stress and Inflammation in Individuals with Post-COVID-19 Condition: A Preliminary Randomized Controlled Trial. Glob Adv Integr Med Health. 2025;14:27536130251385551. Published 2025 Oct 15. doi:10.1177/27536130251385551. https://pmc.ncbi.nlm.nih.gov/articles/PMC12536147/